Cancer research is a lot of scientific effort to understand disease processes engaged and discover possible therapies. Although the understanding of cancer has grown by exhibitor since the last decade of the 20th century, radically new therapies discovered and introduced only gradually.
Tyrosine kinases inhibitors (imatinib and gefitinib) in the late 1990s is considered a major breakthrough, they interfere primarily with the tumor-specific proteins. Monoclonal antibodies have proved a major step forward in oncological care.
Tyrosine kinases inhibitors (imatinib and gefitinib) in the late 1990s is considered a major breakthrough, they interfere primarily with the tumor-specific proteins. Monoclonal antibodies have proved a major step forward in oncological care.
No comments:
Post a Comment